- Dipexium Pharma has filed to raise up to $35M in an IPO on Nasdaq and intends to trade under the ticker symbol DPRX.
- Dipexium is a late-stage pharmaceutical company focused on the development an antibiotic cream call Locilex, which is based on an extract from the skin of the African Clawed Frog.
- Dipexium is initially targeting Locilex for the treatment of mild infections of diabetic foot ulcers. The company plans to start Phase III trials of Locilex in Q2. (S-1)
Dipexium files for $35M IPO
Feb 6 2014, 09:19 ET